Tocopheryl Nicotinate Market

Global Tocopheryl Nicotinate Market Size, Share & Trends Analysis Report By Product Type (Above 97 % Purity, 97 % Purity), By Application (Vascular Disorders, Abnormal Lipid Metabolism, Antioxidants, Skin Conditioning Agents, Cosmetics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Forecast (2021-2027)

Published: Oct 2021 | Report Code: OMR2024310 | Category : Pharmaceuticals | Delivery Format: /

The global market for tocopheryl nicotinate is expected to grow at a significant CAGR during the forecast period (2021-2027). Tocopheryl nicotinate is a tocopherol-nicotinic acid ester. The esterified version of vitamin E (tocopherol) is sold commercially (alpha-tocopheryl acetate, alpha-tocopheryl succinate and alpha-tocopheryl nicotinate). Antioxidant and vasodilatory effects of alpha-tocopheryl nicotinate. It can be used as a gentle warming agent without the redness that nicotinic acid is known for. Tocopherol is authorised in Japan under the trade name Juvela N for the treatment of symptoms associated with hypertension, hyperlipidemia, and peripheral circulatory disruption caused by arteriosclerosis obliterans. Platelet aggregation is inhibited by tocopherol.

Natural components, such as vitamins and minerals, are included in an expanding number of skincare products now in the market to preserve healthy and beautiful skin. As a result, there is a huge need for tocopheryl nicotinate in cosmetics. This comprises skincare products that include tocopheryl nicotinate and provides UVA and UVB protection, such as sun protection SPF formulations. Thus, the increasing demand for tocopheryl nicotinate as skin conditioning agents is expected to drive market growth during the forecast period.

According to WHO, cardiovascular diseases (CVDs) remain the leading cause of mortality globally. CVDs claimed the lives of 17.9 million individuals globally in 2019, accounting for 32% of all fatalities. Heart attacks and strokes were responsible for 85% of these fatalities. Low- and middle-income nations account for about three-quarters of CVD fatalities. CVDs were responsible for 38% of the 17 million premature deaths (before the age of 70) caused by noncommunicable illnesses in 2019. Tocopheryl nicotinate is used as an anti-cholesterol to reduce the risks of cardiovascular disorders. Therefore the rising prevalence of CVDs is expected to drive the growth of the global tocopheryl nicotinate market.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- 

o By Product Type 

o By Application 

o By Distribution Channel 

  • Regions Covered

o North America

o Europe

o Asia-Pacific

o Rest of the world

  • Competitive Landscape: Beijing Brilliance Bio, Cosmol Co. Ltd., TRI-K Industries, Beijing Brilliance Biochemical Co. Ltd., Hangzhou Dayangchem Co. Ltd.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Tocopheryl Nicotinate Market by Segments 

By Product Type

  • Above 97 % Purity
  • 97 % Purity

By Application

  • Vascular Disorders
  • Abnormal Lipid Metabolism
  • Antioxidants
  • Skin Conditioning Agents
  • Cosmetics

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Global Tocopheryl Nicotinate Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

REQUEST FOR TABLE OF CONTENT